ACI
NVAX icon

AMP Capital Investors’s Novavax NVAX Stock Holding History

AMP Capital Investors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13,788
Closed -$2.86M – 736
2021
Q3 		$2.86M Sell
13,788
-1,065
-7% -$235K 0.02% 668
2021
Q2 		$3.15M Buy
+14,853
New +$2.72M 0.02% 700
2021
Q1 		– Sell
-7,349
Closed -$874K – 1287
2020
Q4 		$874K Buy
7,349
+397
+6% +$42.2K ﹤0.01% 876
2020
Q3 		$750K Buy
+6,952
New +$847K ﹤0.01% 865

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

AMP Capital Investors's NVAX Position: Q4 2021 in Review

AMP Capital Investors sold out of Novavax (NVAX) in Q4 2021, closing a stake of 13,788 shares — an estimated $2.86M sold.

AMP Capital Investors first reported a position in NVAX in Q3 2020 and held it in 4 quarters. The position peaked at $3.15M in Q2 2021. 430 funds tracked by Wall St. Rank hold NVAX as of Q4 2021.

  • AMP Capital Investors reported no remaining Novavax position as of Q4 2021 after selling out during the quarter.
  • AMP Capital Investors sold 13,788 Novavax shares in Q4 2021, an estimated $2.86M.
  • AMP Capital Investors first reported a position in Novavax in Q3 2020 and held it in 4 quarters.
  • AMP Capital Investors's Novavax position peaked at $3.15M in Q2 2021.
  • 430 funds tracked by Wall St. Rank held Novavax as of Q4 2021.

Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.